The 3rd edition of Vitafoods India, organised by Informa Markets in India, India’s leading B2B exhibition organiser, successfully concluded at the Jio World Convention Center, Mumbai. Held from 5th to 7th February 2025, the event further strengthened its position as India’s leading platform for the nutraceutical industry.
This year, the event saw 9,207 attendees, marking an impressive 28% increase from last year. The exhibitor presence also grew significantly, with over 160 exhibitors, reflecting a 55% growth compared to the previous edition. Over 35 expert speakers shared insights on market trends, regulatory advancements, and product innovations, engaging key industry stakeholders such as distributors, procurement managers, R&D specialists, regulatory affairs professionals, and product development experts.
Vitafoods India 2025 solidified its position as a leading networking and knowledge-sharing hub for the nutraceutical ecosystem. Amid projections of India’s nutritional supplements market reaching USD 68.42 billion by 2030 at a CAGR of 8.0%, the event served as a critical platform for exploring innovations and opportunities driving the future of health and wellness.
The esteemed expo was graced by distinguished dignitaries, including Chief Guest Dr. Subrata Gupta, IAS, Secretary, Ministry of Food Processing Industries, Govt. of India ; Dr. Manoj Nesari, Advisor, Ayurveda, Ministry of AYUSH, Govt. of India; Mumbai; Dr. Meenakshi Singh, Chief Scientist, Technology Management Directorate, Council of Scientific & Industrial Research (CSIR); Ms. Natasha Berrow, Executive Vice President – Food, Informa Markets; Mr. Yogesh Mudras, Managing Director Informa Markets in India and Mr. Rahul Deshpande, Sr. Group Director Informa Markets in India among other guests.
Addressing at the event Dr. Subrata Gupta, IAS, Secretary, Ministry of Food Processing Industries, Govt. of India, said “The global nutrition market, valued at approximately $520 billion, is witnessing a growing emphasis on traditional and preventive healthcare. India’s share, estimated around $8 billion, highlights the sector’s vast potential, particularly in Ayurveda-based nutraceuticals. The industry plays a pivotal role in bridging the gap between traditional knowledge and modern healthcare by ensuring accessibility, traceability, and quality of herbal and plant-based products. With increasing global demand, standardization, research-backed validation, and sustainable cultivation practices are critical to strengthening India’s position as a leader in the natural wellness sector. Addressing challenges such as quality planting materials, processing gaps, and export compliance can significantly enhance the sector’s contribution to farmers, employment, and foreign exchange earnings. By leveraging advanced processing techniques like gamma irradiation to improve shelf life and expanding institutional support for small and medium enterprises, India is poised to not only reclaim its 5,000-year-old legacy in Ayurveda but also emerge as a dominant force in the international wellness industry.”
Dr. Manoj Nesari, Advisor, Ayurveda, Ministry of AYUSH, Govt. of India, said, “The Ayurveda and nutraceutical sector is experiencing unprecedented growth, with the market expanding from $3 billion in 2014 to $18.2 billion by 2020 and currently valued at around $24 billion. With a projected target of $200 billion over the next decade, this growth is driven by increasing global acceptance, research advancements, and policy support. The industry is evolving beyond conventional supplements to embrace Ayurvedic Aahar, recognizing the immense potential of flavonoids and alkaloids found in medicinal plants and everyday foods. The thin line between food and medicine highlights the significance of functional ingredients like turmeric, amla, and triphala in promoting holistic well-being. Addressing key public health concerns, such as iron deficiency anemia, requires a shift from mere supplementation to improving nutrient absorption, a focus highlighted by initiatives like Mission Utkarsh. Moreover, amendments to the Food Security Act emphasize the importance of nutrition beyond caloric intake. With Ayurveda extending into veterinary applications and Agro Ayurveda ensuring a sustainable supply chain, India is well-positioned to integrate traditional knowledge with modern health solutions. As global interest in Ayurveda and medical value travel continues to rise, the sector stands at the forefront of fostering both industry growth and societal well-being.”
Salman Mehkri, Head of Business Development, Bio-gen Extracts “The Indian nutraceutical industry is currently valued at approximately $5–6 billion and is witnessing rapid growth, with a projected CAGR of 12–13%. This strong momentum is expected to double the industry’s size within the next 4–5 years. With increasing consumer awareness, rising disposable incomes, and high-quality products entering the market, we see tremendous potential. The industry has also set an ambitious goal of reaching $100 billion by 2047, coinciding with India’s 100th year of independence. Government support is crucial for accelerating this industry’s expansion. Policies such as reducing the GST on nutraceuticals from the current 18% to a more consumer-friendly 5–12% and introducing PLI-based schemes for manufacturers would enhance affordability and accessibility, especially in tier-2 and tier-3 cities. With the right regulatory and policy support, India’s nutraceutical industry can become a global leader in health and wellness.”
Dr. Meenakshi Singh, Chief Scientist, Technology Management Directorate, Council of Scientific & Industrial Research (CSIR), said “The nutraceutical sector holds immense potential, given India’s rich heritage in botanicals, traditional knowledge, and our leadership in fruits and vegetable production. Recognizing the sector’s challenges, we formed a dedicated task force under the guidance of the Principal Scientific Advisor in 2021, in collaboration with CSIR and key industry leaders. The mission is to address critical gaps, such as the absence of standardized codes for export tracking and regulatory clarity, to foster growth both domestically and globally. We believe that food is not just nourishment but a powerful source of preventive medicine, aiming to reduce healthcare costs through better nutrition. Moving forward, we seek stronger collaboration between industry and research institutions to generate comprehensive scientific data that will propel the nutraceutical industry to new heights.”
Mr. Sanjaya Mariwala, Executive Chairman & Managing Director, OmniActive Health Technologies, said” “India’s rich agricultural potential, coupled with its pharmaceutical expertise, provides a strong foundation for innovation in nutrition, health, and wellness industries. With the right synergy between government policies and industry initiatives, the sector can unlock immense growth opportunities, much like India’s success in the software industry. Given the country’s manufacturing capabilities and scientific talent, achieving a $100 billion market in nutraceuticals is a realistic goal. A focused and collaborative approach can propel India to the forefront of the global nutraceutical landscape, driving industry expansion and enhancing its contribution to global health and wellness.”
Mr. Nishant Chachra, Vice President, Business Development, KSM-66 Ashwagandha, said “At KSM-66 Ashwagandha, we take immense pride in being the global leader in Ashwagandha, holding over 67% of all Ashwagandha exports from India. With exports spanning 53 countries, North America remains our largest market, followed by Europe and the Asia-Pacific region. As per NBJ report, Mood and Mental Health is among the fastest-growing condition category in supplements. In 2023, sales increased by 6.9% to hit $1.53 billion and is expected to remain in the 6.5% to 7% range through 2027 driven by increasing consumer demand for mental wellness products addressing anxiety, stress, and cognitive health. As the global demand for Ashwagandha-based solutions rises, we continue to set industry benchmarks with innovation and clinical research, reinforcing our position as the most trusted name in Ashwagandha.”
Speaking at Vitafoods India 2025, Mr. Yogesh Mudras, Managing Director, Informa Markets in India, said, “Vitafoods India stands as a definitive platform for the nutraceuticals and dietary supplements industry, reflecting its rapid evolution and immense potential. In 2024, the sector experienced remarkable growth driven by consumer demand for personalised and science-backed health solutions, and 2025 is set to build on this momentum. With increasing emphasis on supply chain transparency, digital health integration, and regulatory compliance, stakeholders are well-positioned to address emerging challenges and seize opportunities in this dynamic market. Nutraceuticals now dominate the pharma -supplement market, with evolving regulations like those from FSSAI set to attract investments and foster growth. Vitafoods India continues to play a pivotal role in driving innovation and shaping the future of this thriving industry.”
Vitafoods India 2025 received a strong backing from leading associations, including AHNMI (Association of Herbal and Nutraceutical Manufacturers of India), AFSTI (Association of Food Scientists & Technologists) India (Mumbai Chapter), CASMB (Chamber for Advancement of Small & Medium Businesses), GCCI (The Global Chamber of Commerce & Industry), HADSA (Health Foods and Dietary Supplements Association), SHEFEXIL (Shellac and Forest Products Export Promotion Council) and WIN (Women in Nutraceuticals) .
Vitamin Angels India partnered as the official Cause Partner, collaborating to address childhood malnutrition in underserved regions of India through innovative and scalable nutrition solutions. KSM-66® Ashwagandha reaffirmed its association with Vitafoods India as the title partner for the third consecutive year, reflecting its confidence in the event’s impact and reach.
Key exhibitors included Inhalation Health, Meteoric Biopharmaceutical, Akums Drugs and Pharmaceuticals, Bio-gen Extracts, Colorcon Asia, Omniactive Health Technologies, Crius Life Sciences, Arjuna Natural, Vantage Nutrition, and Fermenta Biotech Limited, showcasing a diverse range of innovations and solutions in the nutraceutical ecosystem.
A Hub for Insightful Discussions and Knowledge Exchange : The 3rd edition of Vitafoods India 2025 successfully featured several unique zones, including the Tasting Zone, Global Trends Zone, and Innovation Zone, which collectively highlighted the latest advancements and emerging trends in the sector. With over 19 engaging sessions and leading industry experts, the event provided a comprehensive platform for discussions on the evolving nutraceutical ecosystem. Blending science, regulation, innovation, and career development, Vitafoods India played a pivotal role in shaping the future of health and wellness.
The opening day delivered an immersive and thought-provoking experience, featuring sessions on India’s regulatory frameworks, weight management, and gut health trends. Key highlights included insights on weight management and gut health trends by Rushikesh Aravkar, Director, India Reports, Mintel, followed by a discussion on India’s regulatory framework by Dr. K.U. Methekar, Joint Director (WR), FSSAI, and Chinmayee Deulgaonkar, Past President, AFSTI (Mumbai Chapter), and Managing Director, FoodChain ID India. Additionally, Hans Verhagen, Founder of Food Safety & Nutrition Consultancy, provided valuable insights on EU regulations for food supplements. The day also spotlighted innovations such as KSM-66 Ashwagandha, presented by Nishant Chachra, Vice President Business Development, KSM-66 Ashwagandha, emphasizing its global success as a functional ingredient for stress and cognition. Panels on delivery system advancements and personalized medicine further enriched discussions, setting a strong foundation for the event.
The second day focused on the intersection of beauty, wellness, and sustainability, featuring insightful sessions and discussions. David J. Foreman, Consultant at Gateway Health Alliances, addressed critical healthcare needs, while a panel discussion on “Integration into Functional Foods and Beverages – Enriching Food Recipes with Value-added Ingredients and Botanicals,” moderated by Dr. Vaibhav Kulkarni, Hon. Secretary of HADSA, provided invaluable industry insights. Dr. Hitesh Verma, Manager of Ingredients at Lonza Capsules & Health Ingredients, demystified collagen, exploring its types and benefits.
A key highlight of the day was the Women in Nutraceuticals (WIN) Discussion, which emphasized how diversity drives innovation and sustainability in the nutraceutical sector. Other notable sessions included “Key Players in Enhancing Cognitive Function and Performance in Alzheimer’s Disease” by Prof. Vijayaraghavan Seshadri, Director of Scientific Affairs at Velbiom Probiotics, and “The India Advantage & Opportunity for the World” by Indroneel Das, Cluster Lead and Chief of Staff at Invest India.
The final day shifted focus to professional development and career growth within the nutraceutical sector. A fireside chat featuring industry leaders, including Vishvajit Karandikar, Business Unit Head – Parenteral Nutrition at Fresenius Kabi, provided valuable insights into career opportunities and industry pathways. The event concluded with CASMB Talks, which highlighted collaborative advancements within the industry and inspired aspiring professionals.
By addressing industry trends, innovations, and professional growth, Vitafoods India 2025 reaffirmed its position as a pivotal event for the nutraceutical ecosystem. From groundbreaking advancements to fostering inclusivity and career opportunities, the event served as an all-encompassing platform for professionals shaping the future of health and wellness.
About Informa Markets.
Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year.
About Informa Markets and our business in India
Informa Markets is owned by Informa PLC, a leading B2B information services group and the largest B2B Events organiser in the world. Informa Markets in India (formerly UBM India) is India’s leading exhibition organizer, dedicated to help specialist markets and customer communities, domestically and around the world to trade, innovate and grow through exhibitions, digital content & services, and conferences & seminars. Every year, we host over 25 large scale exhibitions, 40 conferences, along with industry awards and trainings across the country; thereby enabling trade across multiple industry verticals. In India, Informa Markets has offices in Mumbai and New Delhi.
